Researchers identify drug characteristics that make cancer metastasis therapy more effective

by Tohoku UniversityOptimal osmotic pressure and viscosity ranges for anticancer drug solvents used in lymphatic delivery (blue area). It is applicable to all types of cancer. Credit: Tohoku Univ

Updated on: February 03,2024 20

Researchers identify drug characteristics that make cancer metastasis therapy more effective

by Tohoku UniversityOptimal osmotic pressure and viscosity ranges for anticancer drug solvents used in lymphatic delivery (blue area). It is applicable to all types of cancer. Credit: Tohoku Univ

Updated on:February 03,2024 20

Study: B cells promote liver cancer with dangerous dual strategy

byGerman Cancer Research CenterGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.04.037Inflammatory fatty liver disease (NASH, non alcoholic steatohepa

Updated on: January 16,2024 11

Study: B cells promote liver cancer with dangerous dual strategy

byGerman Cancer Research CenterGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.04.037Inflammatory fatty liver disease (NASH, non alcoholic steatohepa

Updated on:January 16,2024 11

Study: Race, ethnicity may play a role in cause of liver cancer

by University of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainA new analysis of liver cancer has identified racial and ethnic differences and emerging trends for thi

Updated on: January 29,2024 14

Study: Race, ethnicity may play a role in cause of liver cancer

by University of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainA new analysis of liver cancer has identified racial and ethnic differences and emerging trends for thi

Updated on:January 29,2024 14

Treatment strategy for locally advanced liver cancer via novel tri-modality therapy

byThe University of Hong KongCredit: Pixabay/CC0 Public DomainA pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of C

Updated on: January 15,2024 11

Treatment strategy for locally advanced liver cancer via novel tri-modality therapy

byThe University of Hong KongCredit: Pixabay/CC0 Public DomainA pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of C

Updated on:January 15,2024 11

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research

Updated on: January 15,2024 18

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research

Updated on:January 15,2024 18

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024 15

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024 15

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on: May 23,2024 5

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Updated on:May 23,2024 5

Sperm quality unaffected by one course of chemotherapy for early testicular cancer

by European Society for Medical OncologyHuman sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/WikipediaMen with early stage testicular cancer can safely re

Updated on: March 06,2024 12

Sperm quality unaffected by one course of chemotherapy for early testicular cancer

by European Society for Medical OncologyHuman sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/WikipediaMen with early stage testicular cancer can safely re

Updated on:March 06,2024 12

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024 15

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024 15

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on: February 01,2024 20

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on:February 01,2024 20

Stricter alcohol policies related to lower risk of cancer

by Boston Medical CenterCredit: CC0 Public DomainIn a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol polic

Updated on: March 01,2024 17

Stricter alcohol policies related to lower risk of cancer

by Boston Medical CenterCredit: CC0 Public DomainIn a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol polic

Updated on:March 01,2024 17

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Updated on: January 02,2024 9

Potential melanoma target bypasses therapeutic resistance to immune checkpoint blockers

by Jeff Hansen,University of Alabama at BirminghamConstitutive activation of JAK1/2 in IFNγR1KOmelanoma cells. a Identification of a JAK1/2-centric network of activated protein tyrosine ki

Updated on:January 02,2024 9